A prior study pointed to an interesting ability of SS18-SSX, which recruits polycomb repressive complex 2 (PRC2) to ATF2 target genes to repress tumor-suppressor genes encoded by the CDKN2A locus37. The gene discussed is ATF2; the disease is neoplasm.